Exercise testing in the clinical management of patients affected by pulmonary arterial hypertension
- 13 October 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 19 (5) , 960-971
Abstract
Patients affected by pulmonary arterial hypertension (PAH) show a reduced exercise tolerance with early occurrence of dyspnoea and fatigue. The origin of functional capacity limitation is multifactorial and several mechanisms have been proposed, including right heart failure, which leads to a limited increase in cardiac output during exercise, and hyperventilation with a reduced perfusion of properly ventilated alveoli. In addition, abnormalities in arterial blood gases are observed, with the occurrence of hypoxemia and hypocapnia, related to an abnormal ventilation/perfusion match, gas diffusion abnormalities, low mixed venous oxygen saturation and to the development of intra- and extra-pulmonary right-to-left shunts. At present, the 6-minute walking test is the most used method to assess exercise tolerance in PAH; it is also useful to monitor the response to therapy and provides prognostic information. However, the assessment of functional capacity by cardiopulmonary exercise test (CPET) seems to be more complete, because CPET allows for discrimination between the metabolic, cardiovascular and pulmonary components of exercise limitation. Moreover, CPET estimates the severity of disease and assesses patients’ prognosis and response to therapy. In PAH, a typical CPET-response is observed, characterized by a severe reduction in peak VO2, work rate, O2 pulse and anaerobic threshold and by a marked increase in VE/VCO2 slope and in the dead space to tidal volume ratio. However, the use of CPET should be limited to experienced centres. This review will focus on resting lung function and exercise tolerance tests, showing that CPET can provide the physiological explanation of functional limitation in PAH.Keywords
This publication has 54 references indexed in Scilit:
- Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension: Fig. 1—European Respiratory Journal, 2009
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)European Heart Journal, 2009
- Standards for the use of cardiopulmonary exercise testing for the functional evaluation of cardiac patients: a report from the Exercise Physiology Section of the European Association for Cardiovascular Prevention and RehabilitationEuropean Journal of Preventive Cardiology, 2009
- Cardiopulmonary Exercise Testing in the Functional and Prognostic Evaluation of Patients with Pulmonary DiseasesRespiration, 2009
- Impairment of respiratory muscle function in pulmonary hypertensionClinical Science, 2007
- Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertensionEuropean Respiratory Journal, 2007
- End-tidal Pco 2 Abnormality and Exercise Limitation in Patients With Primary Pulmonary HypertensionChest, 2005
- Exercise testing in pulmonary arterial hypertension and in chronic heart failureEuropean Respiratory Journal, 2004
- Evaluation of Breathlessness in Asbestos WorkersAmerican Review of Respiratory Disease, 1987
- Ventilation-perfusion inequality and overall gas exchange in computer models of the lungRespiration Physiology, 1969